Pharmaceuticals in Asia Pacific
Pharmaceuticals in Asia Pacific
SUMMARY
Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Asia-Pacific pharmaceuticals market had total revenues of $305,738.2m in 2019, representing a compound annual growth rate (CAGR) of 4.5% between 2015 and 2019.
- Countries such as China, India and Indonesia are experiencing strong growth due to a bourgeoning middle-class which spends more on health and has a greater awareness of chronic diseases.
- China is the largest market in the region, accounting for 46.6% of its total value in 2019, therefore its performance heavily influences the regions as a whole. The healthcare sector, particularly biopharmaceuticals, has been identified as an area of priority for the Chinese government.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts
- What was the size of the Asia-Pacific pharmaceuticals market by value in 2019?
- What will be the size of the Asia-Pacific pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Asia-Pacific's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What threats do leading players face?
7.6. What has been the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Yangtze River Pharmaceutical Group
8.2. Shanghai Pharmaceutical Co Ltd
8.3. Daewoong Pharmaceutical Co Ltd
8.4. Chong Kun Dang Pharmaceutical Corp
8.5. Daiichi Sankyo Co Ltd
8.6. Takeda Pharmaceutical Company Limited
9 APPENDIX
9.1. Methodology
9.2. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What threats do leading players face?
7.6. What has been the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Yangtze River Pharmaceutical Group
8.2. Shanghai Pharmaceutical Co Ltd
8.3. Daewoong Pharmaceutical Co Ltd
8.4. Chong Kun Dang Pharmaceutical Corp
8.5. Daiichi Sankyo Co Ltd
8.6. Takeda Pharmaceutical Company Limited
9 APPENDIX
9.1. Methodology
9.2. About MarketLine
LIST OF TABLES
Table 1: Asia-Pacific pharmaceuticals market value: $ billion, 2015-19
Table 2: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Asia-Pacific pharmaceuticals market share: % share, by value, 2019
Table 5: Yangtze River Pharmaceutical Group: key facts
Table 6: Yangtze River Pharmaceutical Group: Key Employees
Table 7: Shanghai Pharmaceutical Co Ltd: key facts
Table 8: Shanghai Pharmaceutical Co Ltd: Annual Financial Ratios
Table 9: Shanghai Pharmaceutical Co Ltd: Key Employees
Table 10: Daewoong Pharmaceutical Co Ltd: key facts
Table 11: Daewoong Pharmaceutical Co Ltd: Annual Financial Ratios
Table 12: Daewoong Pharmaceutical Co Ltd: Key Employees
Table 13: Chong Kun Dang Pharmaceutical Corp: key facts
Table 14: Chong Kun Dang Pharmaceutical Corp: Annual Financial Ratios
Table 15: Chong Kun Dang Pharmaceutical Corp: Key Employees
Table 16: Daiichi Sankyo Co Ltd: key facts
Table 17: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 18: Daiichi Sankyo Co Ltd: Key Employees
Table 19: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 20: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 21: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 22: Takeda Pharmaceutical Company Limited: key facts
Table 23: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 24: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 25: Takeda Pharmaceutical Company Limited: Key Employees
Table 26: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 1: Asia-Pacific pharmaceuticals market value: $ billion, 2015-19
Table 2: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Asia-Pacific pharmaceuticals market share: % share, by value, 2019
Table 5: Yangtze River Pharmaceutical Group: key facts
Table 6: Yangtze River Pharmaceutical Group: Key Employees
Table 7: Shanghai Pharmaceutical Co Ltd: key facts
Table 8: Shanghai Pharmaceutical Co Ltd: Annual Financial Ratios
Table 9: Shanghai Pharmaceutical Co Ltd: Key Employees
Table 10: Daewoong Pharmaceutical Co Ltd: key facts
Table 11: Daewoong Pharmaceutical Co Ltd: Annual Financial Ratios
Table 12: Daewoong Pharmaceutical Co Ltd: Key Employees
Table 13: Chong Kun Dang Pharmaceutical Corp: key facts
Table 14: Chong Kun Dang Pharmaceutical Corp: Annual Financial Ratios
Table 15: Chong Kun Dang Pharmaceutical Corp: Key Employees
Table 16: Daiichi Sankyo Co Ltd: key facts
Table 17: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 18: Daiichi Sankyo Co Ltd: Key Employees
Table 19: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 20: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 21: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 22: Takeda Pharmaceutical Company Limited: key facts
Table 23: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 24: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 25: Takeda Pharmaceutical Company Limited: Key Employees
Table 26: Takeda Pharmaceutical Company Limited: Key Employees Continued
LIST OF FIGURES
Figure 1: Asia-Pacific pharmaceuticals market value: $ billion, 2015-19
Figure 2: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2019
Figure 10: Asia-Pacific pharmaceuticals market share: % share, by value, 2019
Figure 1: Asia-Pacific pharmaceuticals market value: $ billion, 2015-19
Figure 2: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2019
Figure 10: Asia-Pacific pharmaceuticals market share: % share, by value, 2019
